Last updated: 3 months ago
Neuphoria Therapeutics Inc. Q4 2024 Financial Report: Challenges and Strategic Outlook
Explore Neuphoria Therapeutics Inc.'s Q4 2024 financial performance, highlighting net losses, liquidity issues, and strategic partnerships. A hold recommendation is advised.